Prof. Dr. Demet Cansaran-Duman is a distinguished academic and researcher in the field of biotechnology and pharmaceutical sciences. She completed her undergraduate studies at Ankara University, Faculty of Science in 1999, and later earned her PhD in 2007 from the same institution, specializing in drug candidate molecules derived from biological organisms. After completing her PhD, Dr. Cansaran-Duman took a pivotal role at the Refik Saydam Hygiene Center Presidency (TITCK), where she directed the National Drug and Cosmetic Reference Laboratory starting in 2007.

In July 2012, she achieved the rank of associate professor at the Biotechnology Institute of Ankara University. Her scholarly work includes numerous articles and book chapters focused on drug candidate molecules and their applications in medicine. Prof. Duman has been actively involved in leading and coordinating significant projects, such as the Erasmus+ Strategic Partnership Project "Keep Lab Safety Keep You Healthy." Her research has garnered substantial support from various institutions, including TUBITAK, TAGEM, KOSGEP, and the Ankara Development Agency, particularly for her work on in vitro and in vivo applications of new drug candidate molecules.

Prof. Duman's research extends to the therapeutic effects of new drug candidate molecules and miRNAs in diagnosing and treating various types of cancer, with her contributions leading to a patent application for a novel candidate molecule. Her experience in Good Laboratory Practice (GLP), Good Manufacturing Practice (GMP), and licensing, gained during her tenure at TITCK, has informed her teaching; she has been offering courses on GLP, GMP, and drug analysis at the Biotechnology Institute since 2012.

Additionally, she serves as a member of the European Pharmacopeia, Biotechnological Medicines Working Group, and since 2016, she has been the supervisory specialist for DEVA Drug Company's biotechnological drug production project. Prof. Duman continues to be a key figure in her field, contributing to the advancement of pharmaceutical biotechnology through her research, teaching, and professional service.